IBEX TECHNOLOGIES INC (IBT.CA) Stock Fundamental Analysis

TSX-V:IBT • CA4489375085

1.44 CAD
0 (0%)
Last: Apr 5, 2024, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, IBT scores 6 out of 10 in our fundamental rating. IBT was compared to 22 industry peers in the Biotechnology industry. IBT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IBT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year IBT was profitable.
  • In the past year IBT had a positive cash flow from operations.
  • Of the past 5 years IBT 4 years were profitable.
  • Of the past 5 years IBT 4 years had a positive operating cash flow.
IBT.CA Yearly Net Income VS EBIT VS OCF VS FCFIBT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M 3M

1.2 Ratios

  • IBT has a better Return On Assets (22.64%) than 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 28.25%, IBT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.83%, IBT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IBT had an Average Return On Invested Capital over the past 3 years of 9.26%. This is below the industry average of 11.54%.
Industry RankSector Rank
ROA 22.64%
ROE 28.25%
ROIC 6.83%
ROA(3y)14.54%
ROA(5y)7.95%
ROE(3y)18.48%
ROE(5y)9.94%
ROIC(3y)9.26%
ROIC(5y)N/A
IBT.CA Yearly ROA, ROE, ROICIBT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1.3 Margins

  • The Profit Margin of IBT (51.82%) is better than 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of IBT has grown nicely.
  • IBT has a Operating Margin of 19.58%. This is amongst the best in the industry. IBT outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of IBT has grown nicely.
  • IBT has a Gross Margin of 71.29%. This is amongst the best in the industry. IBT outperforms 88.00% of its industry peers.
  • In the last couple of years the Gross Margin of IBT has grown nicely.
Industry RankSector Rank
OM 19.58%
PM (TTM) 51.82%
GM 71.29%
OM growth 3Y11.49%
OM growth 5YN/A
PM growth 3Y41.01%
PM growth 5YN/A
GM growth 3Y6.79%
GM growth 5Y12.72%
IBT.CA Yearly Profit, Operating, Gross MarginsIBT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • IBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • IBT has less shares outstanding than it did 1 year ago.
  • IBT has a better debt/assets ratio than last year.
IBT.CA Yearly Shares OutstandingIBT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
IBT.CA Yearly Total Debt VS Total AssetsIBT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

  • An Altman-Z score of 4.22 indicates that IBT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.22, IBT belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
  • IBT has a debt to FCF ratio of 1.60. This is a very positive value and a sign of high solvency as it would only need 1.60 years to pay back of all of its debts.
  • IBT has a Debt to FCF ratio of 1.60. This is amongst the best in the industry. IBT outperforms 96.00% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that IBT is not too dependend on debt financing.
  • IBT has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: IBT outperforms 52.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.6
Altman-Z 4.22
ROIC/WACC0.89
WACC7.68%
IBT.CA Yearly LT Debt VS Equity VS FCFIBT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

  • IBT has a Current Ratio of 5.08. This indicates that IBT is financially healthy and has no problem in meeting its short term obligations.
  • IBT has a better Current ratio (5.08) than 76.00% of its industry peers.
  • IBT has a Quick Ratio of 4.97. This indicates that IBT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.97, IBT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.08
Quick Ratio 4.97
IBT.CA Yearly Current Assets VS Current LiabilitesIBT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 139.95%, which is quite impressive.
  • IBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 59.15% yearly.
  • The Revenue has decreased by -0.82% in the past year.
  • IBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.64% yearly.
EPS 1Y (TTM)139.95%
EPS 3Y59.15%
EPS 5YN/A
EPS Q2Q%20.09%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y12.87%
Revenue growth 5Y9.64%
Sales Q2Q%17.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IBT.CA Yearly Revenue VS EstimatesIBT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.00, the valuation of IBT can be described as reasonable.
  • Based on the Price/Earnings ratio, IBT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.05, IBT is valued rather cheaply.
Industry RankSector Rank
PE 9
Fwd PE N/A
IBT.CA Price Earnings VS Forward Price EarningsIBT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IBT is valued cheaper than 96.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBT indicates a rather cheap valuation: IBT is cheaper than 92.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.47
EV/EBITDA 14.11
IBT.CA Per share dataIBT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • IBT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

IBEX TECHNOLOGIES INC

TSX-V:IBT (4/5/2024, 7:00:00 PM)

1.44

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)12-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.30M
Revenue(TTM)7.80M
Net Income(TTM)4.04M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9
Fwd PE N/A
P/S 4.53
P/FCF 34.47
P/OCF 15.87
P/B 2.47
P/tB 2.47
EV/EBITDA 14.11
EPS(TTM)0.16
EY11.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY2.9%
OCF(TTM)0.09
OCFY6.3%
SpS0.32
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.64%
ROE 28.25%
ROCE 9.74%
ROIC 6.83%
ROICexc 15.45%
ROICexgc 15.45%
OM 19.58%
PM (TTM) 51.82%
GM 71.29%
FCFM 13.13%
ROA(3y)14.54%
ROA(5y)7.95%
ROE(3y)18.48%
ROE(5y)9.94%
ROIC(3y)9.26%
ROIC(5y)N/A
ROICexc(3y)24.64%
ROICexc(5y)N/A
ROICexgc(3y)24.64%
ROICexgc(5y)N/A
ROCE(3y)13.2%
ROCE(5y)N/A
ROICexgc growth 3Y5.1%
ROICexgc growth 5YN/A
ROICexc growth 3Y5.1%
ROICexc growth 5YN/A
OM growth 3Y11.49%
OM growth 5YN/A
PM growth 3Y41.01%
PM growth 5YN/A
GM growth 3Y6.79%
GM growth 5Y12.72%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.6
Debt/EBITDA 0.69
Cap/Depr 254.79%
Cap/Sales 15.38%
Interest Coverage 250
Cash Conversion 111.33%
Profit Quality 25.34%
Current Ratio 5.08
Quick Ratio 4.97
Altman-Z 4.22
F-Score6
WACC7.68%
ROIC/WACC0.89
Cap/Depr(3y)113.33%
Cap/Depr(5y)77.81%
Cap/Sales(3y)6.8%
Cap/Sales(5y)4.77%
Profit Quality(3y)120.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.95%
EPS 3Y59.15%
EPS 5YN/A
EPS Q2Q%20.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y12.87%
Revenue growth 5Y9.64%
Sales Q2Q%17.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.47%
EBIT growth 3Y25.85%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.16%
FCF growth 3Y-0.7%
FCF growth 5Y47.39%
OCF growth 1Y42.74%
OCF growth 3Y17.98%
OCF growth 5Y59.75%

IBEX TECHNOLOGIES INC / IBT.CA FAQ

Can you provide the ChartMill fundamental rating for IBEX TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to IBT.CA.


What is the valuation status of IBEX TECHNOLOGIES INC (IBT.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to IBEX TECHNOLOGIES INC (IBT.CA). This can be considered as Fairly Valued.


What is the profitability of IBT stock?

IBEX TECHNOLOGIES INC (IBT.CA) has a profitability rating of 8 / 10.


What is the valuation of IBEX TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IBEX TECHNOLOGIES INC (IBT.CA) is 9 and the Price/Book (PB) ratio is 2.47.